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Identification of cis-Acting Sequences Responsible for Phorbol Ester
Induction of Human Serum Amyloid A Gene Expression via a
Nuclear Factor KB-Like Transcription Factor
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We have analyzed the 5'-flanking region of one of the genes coding for the human acute-phase protein, serum
amyloid A (SAA). We found that SAA mRNA could be increased fivefold in transfected cells by treatment with
phorbol 12-myristate 13-acetate (PMA). To analyze this observation further, we placed a 265-base-pair 5' SAA
fragment upstream of the reporter chloramphenicol acetyltransferase (CAT) gene and transfected this
construct into HeLa cells. PMA treatment of these transient transfectants resulted in increased CAT
expression. Nuclear proteins from PMA-treated HeLa cells bound to this DNA fragment, and methylation
interference analysis showed that the binding was specific to the sequence GGGACTTTCC (between -82 and
-91), a sequence previously described by R. Sen and D. Baltimore (Cell 46:705-716, 1986) as the binding site
for the nuclear factor NFKB. In a cotransfection competition experiment, we could abolish PMA-induced CAT
activity by using cloned human immunodeficiency virus long-terminal-repeat DNA containing the NFKB-
binding sequence. The same long-terminal-repeat DNA containing mutant NFKB-binding sequences (G. Nabel
and D. Baltimore, Nature [London] 326:711-713, 1987) did not affect CAT expression, which suggested that
binding by an NFKB-like factor is required for increased SAA transcription.
Human serum amyloid A (SAA) is a major acute-phase
reactant produced mainly by the liver. During periods of
inflammation and tissue damage, serum levels of SAA can
increase by up to 1,000-fold. SAA is also the precursor
peptide of the amyloid A protein subunit of amyloid fibrils in
secondary, or reactive, amyloidosis (24). Insoluble fibrils are
deposited extracellularly in multiple organs, compromising
their normal function. This is a serious complication of
chronic or recurrent inflammatory conditions, e.g., juvenile
chronic arthritis, in which persistently high serum levels of
SAA are found. More than one human SAA gene exist (16,
25, 41), and in mice three active SAA genes and a
pseudogene have been described (29, 51). Both human and
murine SAA gene expression can be induced by the cyto-
kines interleukin-1 (IL-1) and tumor necrosis factor (39, 49).
We have previously characterized a human SAA gene,
SAAg9, and have demonstrated that expression of this gene
can be induced by both of these cytokines in transfected
mouse L cells (49). How these factors mediate control of
gene expression is unknown. To study the mechanism of the
regulation of human SAA gene expression, we have charac-
terized the 5'-flanking region of the gene by DNA sequence
analysis. Using DNA constructs containing part of 5'-
flanking region of SAA upstream of the reporter chloram-
phenicol acetyltransferase (CAT) gene, we have identified a
phorbol ester-inducible enhancer region. We have demon-
strated that a phorbol 12-myristate 13-acetate (PMA)-induc-
ible nuclear protein factor(s) binds to the sequence GG-
GACTTTCC, a sequence first described by Sen and
Baltimore (44) to bind the nuclear factor NFKB, and that this
binding is required for enhancer activity.
* Corresponding author.
t Present address: AFRC Physiology and Genetics Research
Station, Roslin, Midlothian EH25 9PS, United Kingdom.
MATERIALS AND METHODS
DNA sequence analysis. DNA sequence analysis was per-
formed by the chain termination method of Sanger et al. (42).
DNA fragments from the 5'-flanking region of the SAA
genomic clone, SAAg9 (49), were subcloned into M13mpl8
and -mpl9 and sequenced by using sequence-specific oligo-
nucleotides generated on an Applied Biosystems automated
nucleotide synthesizer.
Plasmid-constructions. A 265-base-pair (bp) Sau3A DNA
fragment, from the promoter region and 33 bp of the first
exon of the human SAA gene, was cloned between the
BglII-BamHI sites of the vector, pTK.CAT3 (31). This
construct contains the entire CAT gene, and the thymidine
kinase promoter has been replaced with the SAA 5'-flanking
region. As a control, the thymidine kinase promoter was
deleted from pTK.CAT3 with BglII-BamHI. The subsequent
constructs, OCAT/265 and OCAT, were used to study PMA
inducibility conferred on the CAT gene by the SAA pro-
moter region.
The 265-bp promoter fragment was also cloned into the
BamHI site of the vector pBluescriptSK, generating plasmid
9-2. This vector contains both T3 and T7 promoters flanking
the cloned insert, and it was used to generate both coding-
and noncoding-strand cRNA probes used for RNase map-
ping.
Wild-type (AGGGACTTTCC) and mutant (ACTCACTT
TCC) NFKB-binding sequences from the human immunode-
ficiency virus type 1 (HIV-1) long terminal repeat (LTR)
(32), cloned into plasmid pGEM, were kindly provided by G.
Nabel for cotransfection-competition studies.
Cell lines and DNA transfections. HeLa cells were cultured
in minimal essential medium with 10% heat-inactivated fetal
calf serum in 5% C02, and mouse L cells were cultured in
Dulbecco modified Eagle medium with 10% heat-inactivated
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ETGCCCAGGC TGGGCCTCAA ATTCGGGT TCAAGCAGGC CTCCTGCCTT GGCCTCCCAA
GTAGCTGGGA CATATGGCAC ATGCCACCAT GCCTGGCCCA TTTCTAAATT GCTTGTTTGT
-1000
TTGTTATTAC AAATGCCTAG CCCCTCAGGG TATGAACATG GACTGGAGAA GAAGAAACCA
-900
GAGTTGCTGC TATGTCCACC AGCCTCTCTG CATGTCCTGG CCTCAGCCCC CCTGGGCTCT
GGTACTGACC CATCTCTGGC CACCATGCTC CTCCATAAGC CTCTGCAGAG CTAATCTGAC
-800
CCTGTTGATG TTCTCATGAG AGAGTGATCT GAkTGCCCCC TGAACCCCTC CGTGATAATA
CAGCAGACCA AGAGCTCTCC CACCCTTCCC TGCCTGGATG CTGGGCACGT CCCCAGCTGG
-700
GCTGCCTATT TAACGCACCA CACTCTCATT CTCCCAAGGT GGGGCTCCAG GACTAGGCTG
-600
GGGCAGCAGA AAGTCCCCCT CTCTACATTG TCCTTGGCTC AGGAGCCAAC TTAGAAAAAG
CATTTCCAAA GGCTAAGC CAGCGGAGCA GAGATTTTCT GTGCTGAGAA ATATCAGGAC
-500
ATCCAGAGGG GTGGAAGGAG GCTTCCAGGG CACACATGAG ATGTGGCAGG GGTAGGCTGT
CCGTTTTAAA GCTTAAAGCT TTAGACATGA ACTCACAGGG ACTTCAGTCA 6GGTCATCTG
-400
CCATGTGGCC CAGCAGGGCC CATCCTGAGG AAATGACCGG TATAGTCAGG AGCTGGCTGA
-300
AGAGCTGCCC TCACTCCACA CCTTCCAGCA GCCCAGGTGC CGCCATCACG GGGCTCCCAC
TGGCATCTCT GCAGCTGCAC TTCCCCCAAT GCTGAGGAGC AGAGCTGATC TAGCACCCTG
-200
TCCATTGCCA AGGCACAGCA AACCTCTCTT GTTCCCATAG GTTACACAAC TGGGATAAAT
GACCCGGGAT GAAGAAJaCCA CCGGCATCCA GGAACTTGTC TTAGACCAGT TTGTAGGGGA
-100
AATGACCTGC AGGGACTTTC CCCAGGGACC ACATCCAGCT TTTCTTCCCT CCCAAGAGAC
-1+1
CAGCAAGGCT CACTATAAAT AGCAGCCACC TCTCCCTGGC AG&GG3LCcG
GCACACGACG AGGAGCACAC AAGGAGTGAT TTTTAAAACT TACTCTGTIT
FIG. 1. (A) Nucleotide sequence of the 5'-flanking region of a human SAA gene. The nucleotide sequence of the 5'-flanking sequence,
exon 1 (bold face), and part of intron 1 of the SAA gene contained within the genomic clone SAAg9 was determined as described in Materials
and Methods. The repeat sequences described in the text are at -54 to -73 and -187 to -209 and at -128 to -142 and -145 to -159 (direct
repeats) and at -112 to -130 and -205 to -225 (inverted repeats). TATA box and the Sau3A restriction sites used in subsequent cloning of
a 265-bp fragment are underlined. (B) Homologies between the SAA 5' region and other 5' regulatory regions. i, Homologies between SAAg9
and IFN-a consensus sequence; iia, homologies between SAAg9 and mouse SAA1 (mSAA1) and SAA2 (mSAA2); iib, similar spatial
arrangements of homologous regions of human SAAg9 and mouse SAA1 and 2; iii, locations of sequences homologous to the viral enhancer
consensus that binds NFKB (GH, growth hormone; Apo CIII, apolipoprotein CIII); and iv, consensus sequence in the 5'-flanking regions of
IL-1-responsive genes (Strom, stromelysin; FB, factor B; Hp, haptoglobin).
fetal calf serum in 5% CO2. DNA transfections were per-
formed by the calcium phosphate precipitation method (22).
OCAT, OCAT/265, and competitor DNAs were cotrans-
fected with 2 ,ug of plasmid pXGH5 (43), containing the
growth hormone gene. At 24 h after transfection, the pres-
ence of secreted growth hormone was measured by radio-
immunoassay (Allegro human growth hormone assay kit;
Nichols Institute) to monitor the efficiency of DNA uptake
by cells. The growth hormone assay was subsequently used
to normalize the amount of cell extract used in the CAT
assay. PMA was added 24 h after transfection, and cell
extracts were generated at 28 h.
CAT assays. CAT assays were performed by a modifica-
tion of the method described by Crabb and Dixon (13), and
values were normalized for transfection efficiency as men-
tioned above. After autoradiography, the acetylated and
unacetylated forms of chloramphenicol were quantified by
excision and then counting by liquid scintillation.
RNA isolation, RNase mapping, and Northern (RNA) blot
analysis. Total RNA was isolated from semiconfluent petri
dishes of transfected and nontransfected cells by the guani-
dinium isothiocyanate total cell lysis method (9), and the
RNA was purified by ultracentrifugation through a 5.7 M
cesium chloride cushion.
T3 and T7 polymerases were used to generate coding- and
noncoding-strand cRNA probes from recombinant 9-2,
which contains 236 bp of 5' promoter sequence and 33 bp of
the first exon of the SAA gene. These probes were then used
for RNase mapping (30, 52). RNA (15 to 30 Fxg) was annealed
with 105 cpm of a single-stranded probe at 85°C for 5 min and
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ACA TC- CAG CTT T-T CTT CCC T
ACC TCG CAG -TT TCT CTT CTC T
ii)a mSAAl CAG TCT
SAAg9 CAG TTT
mSAA2 CAG TCT
TTA CAA GAA ATG ACT TTT CTG GAG TTT
GTA GGG GAA ATG ACC TGC AGG GAC TTT
TTA CAA GAA ATG ACT TGT CTG GAG TAT
TCC CAA GGG -72
-CC CCA GGG -76
TAC CAA GGG -73
-72 45bp
CAA GGG -- ATAAAT
: : ::: 46bp
CCA GGG ------ TATAAAT
: : ::: 46bp
CAA GGG ------- ATAAAT
20bp
-------- Exonl
22bp
-------- Exonl
20bp
-------- Exonl
iii) Viral Consensus
SAAg9
Factor B
Factor B
Rat GH
Apo CIII
iv)
G GA CC
AGGGACTTTCC
AGGGACTTTCC
-92 -82
ATGGAATTTOC
-467 -457
TGGGACTTCTG
-152 -142
AGGGACGTGACC
-177 -166
AGGGATTTCCC
-157 -147
-270 -262
SAAg9 AGCTGCACT
-205
IL6 AGCTGCACT
-716
FB TGCTGCCCT
-5243
AGP AGATGGACT
-157
Bp iAGCTCAACT
Strom
-347
AGTTCTGCACA
FIG. 1-Continued
then allowed to cool overnight to 40°C. Unprotected RNA
was then removed by incubation with RNase T1 at 30°C for
1 h, and the subsequent fragments were separated on a 12%
urea-polyacrylamide sequencing gel. Northern blot analysis
was performed by electrophoresis of 20 ,g of total RNA
through 1% (wt/vol) agarose gels containing 0.6% (vol/vol)
formaldehyde, transferred to nitrocellulose, and hybridized
by using a 32P-labeled SAA-specific cDNA probe, pAl (46).
Nuclear extract isolation and DNA-binding gel electropho-
resis assay. Nuclear protein extracts were generated essen-
tially by the protocol of Dignam et al. (15), and protein
concentrations were determined by the BCA-1 assay (Sigma
Chemical Co., St. Louis, Mo.).
Analysis of protein-DNA complexes was performed as
described by Sen and Baltimore (44). DNA fragments were
isolated by electrophoretic transfer onto DE-81 ion-
exchange paper, followed by elution in 1.5 M NaCl. DNA-
binding reactions (5 pug protein per 104-cpm fragment) were
carried out at room temperature for 15 to 30 min, with a
preincubation of 15 min for unlabeled competitor DNAs. All
B
i) SAAg9
aIFN
ii)b mSAAl
SAAg9
mSAA2
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FIG. 2. Northern blot of total RNA from PMA-treated trans-
fected cells. Total RNA was isolated from SAAg9-transfected
mouse L cells that were untreated (-) or treated (+) for 4 h with
PMA (50 ng/ml) in the absence of fetal calf serum. A 20-,ug sample
was assayed by Northern blotting, and the filter was probed with
32P-labeled SAA-specific cDNA. After autoradiography, the filter
was washed and reprobed with 32P-labeled mouse a-actin cDNA.
reactions were performed in the presence of 3 ,g of poly(dI-
dC) as nonspecific competitor DNA.
DNA methylation interference assay. DNA methylation
interference was assayed essentially as described by Sen and
Baltimore (44).
30
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5'-Flanking-region sequence of SAAg9. Sequence analysis
of the 5'-flanking region of the SAA gene identified a number
of potential regulatory elements (Fig. 1).
First, there is a TATA box (sequence TATAAAT) be-
tween nucleotides -23 and -29 (Fig. 1A).
Second, we found homology to alpha interferon (IFN-a)
consensus sequence and the 5' region of the complement
factor B gene (Fig. 1B). Between -53 and -72, there is 81%
homology to the IFN-a-responsive consensus element found
in the IFN-a-inducible HLA and metallothionein genes (18).
The factor B gene, another acute-phase gene, contains a
similar sequence (50), showing 73% homology to the corre-
sponding region in the SAA gene.
Third, the three mouse SAA genes contain a region of
significant homology across 26 nucleotides in their 5'-
flanking regions (Fig. 1B; 29). This homology is strongest
between the mouse SAA1 and SAA2 genes. The human SAA
gene contains a sequence bearing 73% homology to this
region across 29 nucleotides, including the 26-nucleotide
region of mouse SAA1 and SAA2. This homology is still 69%
when the sequence region is extended to 41 nucleotides.
Also striking are the similar spatial arrangements of the
human and mouse homologies, all starting between nucleo-
tides -72 and -76. However, the homology is only 50%
when this region is compared with the corresponding region
of mouse SAA3.
Fourth, the 11-nucleotide sequence AGGGACTTTCC,
between -82 and -92, is contained within the sequence
described above and is identical to the enhancer sequence
I I I I I I I
1 2 3 4 5 6 7 8 9 10
pg DNA
FIG. 3. Dose-response curve of CAT expression after PMA stimulation, using different quantities of test DNA in transfection experiments.
Duplicate plates of 106 HeLa cells were transfected with OCAT/265 and OCAT. After 24 h, culture medium was assayed for human growth
hormone, cells were treated with PMA (50 ng/ml) for 4 h, and the CAT assay was performed. Percent conversion to acetylated forms was
normalized to values for growth hormone expressiom Symbols: U, OCAT, no PMA; A, OCAT, PMA treated; 0, OCAT/265, no PMA; *,
OCAT/265, PMA treated.
0
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FIG. 4. Mapping of the transcriptional initiation site of the hu-
man SAA gene. RNase protection analysis was used to identify the
transcriptional start site of the human SAA gene and to determine
whether the SAA 265-bp-directed CAT RNA was initiated at the
same position. The 265-bp 5' SAA fragment (Fig. 1A) was subcloned
into pBluescript and linearized with XbaI or EcoRI to allow synthe-
sis of complementary (positive) or noncomplementary (negative)
cRNA probes. The 35S-labeled probes were annealed with 30 (lanes
1 to 3 and 5 to 7) and 15 (lanes 4 and 8) ,ug of total RNA from
different transfected cells and treated with RNase T1 at 30°C for 1 h;
the resultant fragments were separated on a 12% polyacrylamide
sequencing gel. 32P-labeled nucleotide size markers (shown on the
right) were electrophoresed in a parallel track. Arrows indicate
protected fragments.
GGGGGTTCCCC, identified in simian virus 40, human and
mouse cytomegaloviruses, HIV-1 LTR, and the immuno-
globulin K light-chain enhancers (28). This sequence has
been shown to be a cis-acting transcription element respon-
sive to phorbol esters. Two regions in the factor B gene are
homologous with the sequence (91 and 72%) (50); regions of
homology are also found in the c-erb-A-binding site in the
growth hormone gene (75%) (21) and the 5' region of the
human apolipoprotein CIII gene (91%) (37).
Fifth, between nucleotides -54 and -225 there are two
inverted-repeat regions (21 and 19 bp) and two direct-repeat
regions (Fig. 1A). Also, the upstream portion of one of the
direct-repeat regions bears 79% homology to a 5' repeat
region of'the ,B-fibrinogen gene, another acute-phase gene
(17).
Finally, there is a consensus sequence consisting of 9 bp in
the 5' region of SAA and the IL-1-inducible genes IL-6 (40),
stromelysin (37), complement factor B (50), a,-acid glyco-
protein (AGP; 19), and haptoglobin (33) (Fig. 1B).
Control of SAA gene expression by phorbol esters. It was
previously shown that the sequence GGGACTTTCC is an
enhancer sequence in the immunoglobulin K light-chain gene
and that this sequence is also responsive to phorbol ester
induction in non-B cells. To establish whether the SAA gene
is inducible with phorbol esters, we treated mouse L cells
persistently transfected with the SAA gene SAAg9 with
PMA. Analysis of total RNA by Northern blotting demon-
strated a fivefold increase in SAA RNA levels when cells
were treated with 50 ng of PMA per ml for 4 h (Fig. 2).
Induction of CAT gene activity with phorbol ester by a 5'
DNA fragment of the SAA gene. To investigate whether the
potential enhancer region of the SAA gene is responsive to
induction by PMA, we placed a 265-bp fragment from the 5'
region (from nucleotides -234 to +31), containing the en-
hancer, upstream of the CAT reporter gene and transfected
this DNA construct (OCAT/265) into HeLa cells. The DNA
was cotransfected with 2 ,ug of a human growth hormone
gene as an internal marker for transfection efficiency. Trans-
fections done with various amounts of growth hormone gene
(pXGH5) DNA had indicated maximum growth hormone
activity with 10 ,ug of DNA per 106 cells (data not shown),
although 2 ,ug of growth hormone gene DNA gave a consis-
tently detectable level of growth hormone. Therefore, all
transfection experiments were performed with 10 ,ug ofDNA
in total, consisting of various amounts of test DNA, 2 ,ug of
growth hormone DNA, and Bluescribe plasmid DNA used
as the carrier.
Incubation of the OCAT/265-transfected cells with PMA
for 4 h induced CAT activity approximately 11-fold greater
than the level observed in untreated cells. Titration of the
amounts of transfected DNA revealed a proportional in-
crease in CAT activity with increasing amounts of DNA
(Fig. 3), peaking at 8 ,ug but then decreasing slightly after this
amount. It was also found that the OCAT/265 construct
produced a significant, constitutive level of CAT activity. A
dose-response curve, using 8 ,ug of OCAT/265 DNA, re-
vealed maximum PMA induction of CAT activity at 50 ng/ml
(data not shown).
To establish whether the transcriptional start site for the
SAA-CAT gene construct is the same as the start site for the
SAA gene, RNase mapping was performed on RNA isolated
from cells transfected with both the whole gene and the
OCAT/265 construct. The analyses revealed that transcrip-
tion initiation occurred at exactly the same position when the
whole SAA gene was used or when transcription was di-
rected by just the 265-bp fragment on the CAT gene (Fig. 4).
Specific DNA-binding nuclear protein induced by PMA.
Since (i) PMA was capable of inducing transcription of the
complete SAA gene and (ii) a short 5' region of the gene was
capable of conferring inducibility to a heterologous reporter
gene, DNA-binding proteins from PMA-treated cells were
examined. We isolated total nuclear protein extracts from
untreated and PMA-treated HeLa cells and assayed for
DNA-binding activity by the DNA-binding gel shift assay.
We found strong binding of nuclear proteins from the treated
cells to the 265-bp 5' fragment capable of conferring PMA
responsiveness (Fig. 5A). Furthermore, this binding could
be abolished by using 50 ng of unlabeled fragment as
competitor. Binding could also be abolished by using an
unlabeled HIV-1 LTR DNA fragment. This DNA fragment
has been demonstrated to contain two binding sites for
NFKB (32). DNA binding was not affected when a nonspe-
cific competitor, a 465-bp SAAg9 intron 1 DNA fragment,
was used. We also studied nuclear binding proteins from
mouse L cells persistently transfected with SAAg9. Specific
binding to the 265-bp fragment was found with extracts from
PMA-treated cells, and again the binding could be abolished
with 50 ng of the HIV-1 LTR fragment (Fig. 5A).
Specific binding of an NFKB-like DNA-binding protein. To
delineate the exact binding site of the inducible NFKB-like
DNA-binding protein, DNA methylation interference analy-
sis was performed. Analysis of bound and unbound DNA
strands spanning the 265-bp 5' fragment revealed binding to
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FIG. 5. DNA-binding assays demonstrating binding of an NFKB-like nuclear protein to the SAA 5' region. (A) Nuclear extracts were
isolated from HeLa cells and SAAg9-transfected L cells after PMA treatment (50 ng/ml for 4 h), and 5 ,ug of nuclear protein was incubated
with 104 cpm of the 32P-labeled 265-bp fragment for 15 to 30 min with or without unlabeled competitor DNA. Reaction products were
electrophoresed through a nondenaturing 4% polyacrylamide gel, the gel was dried, and bands were visualized by autoradiography. Arrow
indicates retarded band. Competitor DNAs: 265, 265-bp Sau3A 5' SAA fragment from SAAg9 (Fig. 1A); HIV, 361-bp EcoRV-BgIIH fragment
of HIV-1 LTR DNA; Intron, 465-bp Avall intron 1 fragment of SAAg9. (B) The sequence of the protein-binding region was determined by
methylation interference analysis. The 265-bp fragment was end labeled with 32P, the labeled ends were separated by SmaI digestion, and the
DNA was partially methylated at G residues by incubation with dimethyl sulfate. A large-scale DNA-binding gel electrophoresis assay was
performed on both fragments, and the bound and unbound DNAs were eluted from the gel. The DNA was then cleaved by incubation with
piperidine, and the resultant DNA fraginents were separated by electrophoresis on a 12% polyacrylamide sequencing gel. Asterisks identify
protected G residues.
a region of DNA containing the viral enhancer sequence
GGGACTITCC (Fig. SB). This pattern of binding was
similar to that described for the immunoglobulin enhancer
binding factor NFKB, which is induced in HeLa cells by
PMA.
Induction of CAT activity with phorbol ester by the 5' SAA
gene fragment is via binding of an NFKB-like factor. To
establish whether the NFKB-like factor binding to the 5'
SAA region was responsible for PMA-induced CAT activity,
we cotransfected the OCAT/265 DNA construct with a
fragment from the HIV-1 LTR containing two copies of the
wild-type or mutant NFKB-binding site. This mutant se-
quence was previously shown to abolish the binding of
NFKB transcription factor (32). There was complete aboli-
tion of the PMA-inducible CAT activity with 50 ,ug of
wild-type competitor DNA (Fig. 6). There was no competi-
tion when the cloned mutant NFKB-binding sequence was
used.
DISCUSSION
The acute-phase response results in a dramatic change in
the expression of a group of serum proteins. These changes
can be induced in vivo and in vitro by treatment with
cytokines individually or in combination. Examples include
induction ofSAA (39, 49), complement factors B (36, 39) and
C3 (14, 20), AGP, and haptoglobin (20, 26, 39) by IL-1;
induction of AGP (20, 38), fibrinogen, al-antichymotrypsin,
haptoglobin, cysteine protease inhibitor, and a2-macroglob-
ulin (1, 20) by IL-6; induction of SAA (49), complement C3,
A
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.
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FIG. 6. Cotransfection-competition assay demonstrating that
phorbol ester induction is via an NFKB-like factor. OCAT-265 DNA
(1 ,ug) was cotransfected into PMA-treated HeLa cells (2.5 ng/ml for
2.5 h) with 50 and 100 ,ug of cloned HIV-1 LTR DNA containing
either the wild-type ('GGGACTTT-CC) or the mutant (ACTCACTI
TCC) NFKB-binding site sequence (WT and Mut, respectively).
Equivalent amounts of nonspecific carrier DNA were used in
transfection experiments with OCAT/265 DNA alone. CAT assays
were performed as described in the legend to Fig. 3.
haptoglobin, and AGP (7, 20, 26) by tumor necrosis factor;
and induction of complement factors B and C2 by IFN--y
(47).
5' cis-acting control regions have been identified in a
number of cytokine-responsive acute-phase genes. These
include the IL-1-responsive factor B, AGP, haptoglobin, and
stromelysin genes (19, 34, 38; H. R. Colten, personal com-
munication) and the IL-6-responsive C-reactive protein gene
(3). We have characterized the 5'-flanking region of an SAA
gene and identified a phorbol ester-responsive enhancer
sequence that is activated by binding to an NFKB-like
nuclear protein. It is not yet clear which cytokine(s) acts via
this enhancer region in SAA expression. One candidate
would be IL-1 because PMA can replace IL-1 in lymphocyte
comitogenesis assays (48). Furthermore, recent experiments
(L. Osborn, S. Kunkel, and G. Nabel, Proc. Natl. Acad. Sci.
USA, in press) have shown that IL-1 can induce transcrip-
tion of CAT directed by the HIV-1 LTR via an NFKB-like
factor. Our experiments demonstrate that PMA induces a
moderate 5-fold increase in SAA mRNA, whereas IL-1
produces a >50-fold increase (49). Therefore, PMA can
mimic only part of the action of IL-1 in this system, and the
9-bp consensus sequence (Fig. 1B) found by sequence ho-
mology between the IL-1-inducible genes (SAA, factor B,
AGP, stromelysin, and IL-6) may have functional impor-
tance.
A number of phorbol ester-inducible nuclear proteins have
been identified. These include AP-1, AP-2, AP-3 (2, 10, 27),
and NFKB (44). The binding site for one of these factors,
NFKB, has been identified in a series of viral enhancers,
including HIV, simian virus 40, and cytomegalovirus; it has
also been found upstream of major histocompatibility com-
plex class I genes and in the immunoglobulin K light-chain
gene enhancer. NFKB was found in activated B cells pro-
ducing immunoglobulin K light chain. However, it was also
identified in cells that did not express the K gene (HeLa and
T cells), for which its target genes were unknown. Here we
have demonstrated the probable involvement of NFKB in the
transcription of another cellular gene, SAA. We have char-
acterized a phorbol ester-inducible enhancer sequence from
the 5'-flanking region of an SAA gene and demonstrated
binding of an inducible nuclear factor to a sequence between
-82 and -91 in this fragment, identical to the recognition
sequence of NFKB. PMA-induced CAT activity was abol-
ished by using cloned DNA fragments from the HIV-1 LTR
containing two copies of the recognition sequence in trans-
fection experiments. It is interesting that cloned oligonucle-
otides containing the NFKB-binding sequence did not abol-
ish CAT activity induced by PMA (data not shown), which
indicates the importance of DNA conformation for the
binding of transcription factors. These results suggest that
NFKB or a functionally homologous protein has a role in
transcriptional regulation in non-B cells.
The rapidity of SAA expression in the acute-phase re-
sponse could be accounted for by activation of this region,
since NFKB is present in the cytosol in an inactive state (4)
and is rapidly activated and translocated to the nucleus upon
stimulation of cells with phorbol ester. This process does not
require any new protein synthesis (45). However, NFKB has
yet to be demonstrated in tissues that normally express
SAA. Factors in cell types other than B, T, and HeLa that
have DNA-binding properties very similar to those of NFKB
have been identified. H2TF1, a factor found in most cell
types, binds the sequence GGGGATTCCCC upstream of the
mouse H-2Kb class I major histocompatibility gene (5).
Similarly, the phytohemagglutinin- and PMA-inducible nu-
clear protein HIVEN86A binds to the sequence GGGGAA
TCTCCC, upstream of the IL-2 receptor alpha gene (8, 28).
NFKB also binds with high efficiency to both of these
sequences (6, 8). Moreover, the PMA-inducible factor AP-3
is able to bind an identical sequence in simian virus 40 but is
slightly different in binding characteristics from NFKB (10).
Thus, several closely related protein factors are able to bind
to subtly different 5' enhancer sequences, and any of these
may be the true physiological activator for SAA gene tran-
scription.
Other DNA-binding proteins have been shown to activate
some other acute-phase genes; e.g., hepatocyte-specific nu-
clear factor 1 (HNF1) activates the at- and P- fibrinogen and
a1-antitrypsin genes (12), major late transcription factor
activates the rat -y-fibrinogen gene (11), and LF-A1 and
LF-B1 (or HNF1) activate the al-antitrypsin and haptoglo-
bin genes (23). However, binding sequences for these pro-
teins are absent in the SAA promoter region. Also, the SAA
gene does not contain the heat shock consensus sequence
(35) found in the promoter regions of the C-reactive protein
and factor B genes. Thus, a complex pattern of interactions
between different, readily activatable nuclear factors and
cis-acting DNA sequences of different acute-phase genes is
now emerging. Future comparison of wild-type and mutant
SAA genes should test directly the importance of these
factors in the physiology of the acute-phase response.
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